Clinical Trial Update: Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a Pd-1 antibody combined with concurrent chemoradiotherapy for local advanced cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Cervical Cancer | Phase 1, Phase 2 | Status: UNKNOWN